Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence? - Wikidata - awgldk - TriplyDB

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

http://www.wikidata.org/entity/Q37179048

about

The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice.Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer's Disease-like Neurotoxicity.Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Tau deletion promotes brain insulin resistance Metabolic network failures in Alzheimer's disease: A biochemical road map.Sorting receptor SORLA: cellular mechanisms and implications for disease.Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers.The beneficial effects of dietary restriction on learning are distinct from its effects on longevity and mediated by depletion of a neuroinhibitory metabolite.Suppression of adiponectin receptor 1 promotes memory dysfunction and Alzheimer's disease-like pathologies.Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.Regulation of brain insulin signaling: A new function for tau.Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.Interactions between stress and physical activity on Alzheimer's disease pathology.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.

P2860

Q37445026-F234165D-6F5F-49F7-AFD3-B819B7ED2736 Q38633186-C4FD7C4E-6DC9-4FC1-8BB1-D75272C07D19 Q38659874-218FD3EB-5CF0-42BE-9347-B6CC9FECE2C2 Q38708062-CF1124C8-6626-46BF-A472-EA1E60A5C4F6 Q38877855-7F250082-5264-4F50-91FB-FE1DEFCEE6B7 Q39004592-2E284BD8-841F-424E-8E99-B3C0F3EAEB35 Q39211852-DAECCE03-B8AA-40F8-9325-100BF3682E23 Q41200235-7D60DB1A-F66C-4385-8803-C78DB5913459 Q42367763-B1CABFA8-0E8D-4205-B35E-7EECE59FCCFB Q45754969-82DB1E7D-3853-42B4-9C6D-1EDB2606F4CB Q47732929-E79A1151-E3F1-44C8-B889-988BBB0A6FE4 Q47831375-7A7EDC1F-6661-4C82-97E2-33DD757D4664 Q47835103-54FA5838-A50F-4873-81E2-00B8DA9F77E6 Q48223283-0F4E8D99-5D33-42F4-8262-A698BC20DDDE Q49659203-D97C4300-219D-4BD6-AA98-DEA1D664FD4B Q55083969-299AD0DD-0171-451F-B3E7-4941CC8D3469 Q55353865-EC83D06A-F291-42DC-A5A1-A59590904C3B

P2860

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

http://www.wikidata.org/entity/Q37179048

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@en

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@nl

type

label

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@en

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@nl

prefLabel

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@en

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@nl

P1433

Q37179048-A076AAB0-E45B-4A5F-AD27-936BE772AD94

P1476

Q37179048-FF406241-F411-4FF8-AD20-DFCCCD76FCD0

P2860

Q37179048-026988B7-E988-46B7-9A6C-2E9AD37D6294

Q37179048-04AD6342-E84E-4B96-B36D-222F64829BBF

Q37179048-06F0DC50-C122-48F5-878A-4DDB1B70608E

Q37179048-0CDE7427-5299-456B-BB75-92B420EB2E72

Q37179048-1325DB04-1C2E-408C-AF5A-939FC4882BB0

Q37179048-14F888AA-50EE-4EB2-9555-99184D44CD58

Q37179048-1624A1E9-C0FC-4368-95F1-95CFC69FB784

Q37179048-16384CE6-E946-475F-BE77-B16F3DCC83A5

Q37179048-17685EEC-F024-4706-A8D2-0A58D34ED54B

Q37179048-1ACDD58A-046A-4D81-9EF3-98AEDFFC6626

P304

Q37179048-9E7A154A-1062-4AF1-9E5E-BFA9D6CD3931

P31

Q37179048-2A523871-77E6-4B71-B242-4C713C9BEECD

Q37179048-F90EF47C-0F4A-4683-BCA7-E0E7448A3219

P356

Q37179048-BC9CFDF1-1F57-4C0A-8E37-5332F62D9254

P407

Q37179048-B3BC37DF-D62F-4FA0-8873-4F5459F47DEE

P433

Q37179048-9D8AF210-C510-41B4-A72E-15FCC94DD48A

P478

Q37179048-12DEBB5F-0D65-4EB4-988D-03CF5AD84DD2

P50

Q37179048-24FD3F8A-E124-4992-A016-CEFCE3CB1C06

Q37179048-76B98917-02B7-4AD9-ACF7-ECCA6DA78A24

Q37179048-8C03FE30-8732-445C-84CF-3C94F3C3BBF0

P577

Q37179048-31E69FF0-5F04-4A37-A9DC-2D34C0C38B88

Q37179048-84FA07FF-CE79-45AA-92B3-AF5B90674A4D

P698

Q37179048-FA5883AB-65A8-4F8D-8304-7B9C2125AA93

P921

Q37179048-068A2C40-E679-4B91-AF5A-182502816294

Q37179048-419DC152-2A14-48BB-B3C4-21D7962231D6

Q37179048-4791FD9D-93A0-46E4-8979-B1ACA0FBD65C

Q37179048-95BD80C1-6FCA-4DA2-91AA-F389B401672D

Q37179048-9AC17132-123F-435A-A446-0312F4BDFD20

Q37179048-C57ACF97-84F6-42ED-A073-87E6D7AFCC35

P932

Q37179048-5BA0ECE4-F194-468F-A473-810ECDB9027F

P356

P1433

Journal of Experimental Medicine

P1476

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

@en

P2860

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report

The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier?

Three dimensions of the amyloid hypothesis: time, space and 'wingmen'

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.

P304

1375-1385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20160493

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

213

http://www.w3.org/2001/XMLSchema#string

P50

David M. Holtzman

Shannon L Macauley

P577

2016-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27432942

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

type-2 diabetes

maturity-onset diabetes of the young

P932

4986537

http://www.w3.org/2001/XMLSchema#string